Inconsistently, the current study demonstrated that NOTCH1, JAG-1, JAG-2, and survivin, as a down target molecule of NOTCH pathway, significantly decrease in women with PCOS, endometriosis, and RIF. This evidence concerns the gene JAG2 and polycystic ovary syndrome.